Home background BioSolveIT expect
actives!
BioSolveIT visualizes drug discovery.
Our fast and easy-to-use software enables every chemist to effortlessly advance their research.
Download Learn more

blue background HIV complex Discover our services Want us to find
actives for you?
research

Lead the field

Work with precision at unrivaled speed to make informed decisions backed up by science. To meet the challenges of modern drug discovery, take advantage of BioSolveIT’s detailed and precise results — without compromise. We will address every step of your needs, from start to finish.

partners

Discover with confidence

Profit from our long-standing experience and collaboration history with Fortune 100 pharma companies and academia. Our secure software has been developed and backed by renowned partners - including BAYER, Roche, Merck, BASF, and others. BioSolveIT’s success record is cited in thousands of publications worldwide.

start right away

Start right away

BioSolveIT’s technology is fine-tuned for the needs of the pharma industry, academics, beginners, and veterans alike. Clean and compherensive user interface removes the need for a learning curve. Easy access fostered by intuitive operation will maximize the likelihood of your success. Simply download the multiplatform software and discover active molecules!

drug discovery evolution

Experience drug discovery

Evolve the way you approach drug design, with the most liberating breakthrough. The stimulating interface creates a dialog between you and your compound where you can see why something is considered good or bad. Clean visualization combined with scientific finesse mold into a fun-to-use drug design experience.

research

Lead the field

Work with precision at unrivaled speed to make informed decisions backed up by science. To meet the challenges of modern drug discovery, take advantage of BioSolveIT’s detailed and precise results — without compromise. We will address every step of your needs, from start to finish.

partners

Discover with confidence

Profit from our long-standing experience and collaboration history with Fortune 100 pharma companies and academia. Our secure software has been developed and backed by renowned partners - including BAYER, Roche, Merck, BASF, and others. BioSolveIT’s success record is cited in thousands of publications worldwide.

start right away

Start right away

BioSolveIT’s technology is fine-tuned for the needs of the pharma industry, academics, beginners, and veterans alike. Clean and compherensive user interface removes the need for a learning curve. Easy access fostered by intuitive operation will maximize the likelihood of your success. Simply download the multiplatform software and discover active molecules!

drug discovery evolution

Experience drug discovery

Evolve the way you approach drug design, with the most liberating breakthrough. The stimulating interface creates a dialog between you and your compound where you can see why something is considered good or bad. Clean visualization combined with scientific finesse mold into a fun-to-use drug design experience.

blue background Scientific Challenge Succeed with
your research
Scientific Challenge

Current news

Take off with CHEMriya - OTAVA's On-Demand Chemical Space
May 7, 2021 09:00

We are proud the to announce the new on-demand Chemical Space ‘CHEMriya’, created in partnership with OTAVA. The Chemical Space is named after the famous Antonov An-225 Mriya, the biggest cargo aircaraft ever built. The first release of the CHEMriya Space contains 11 billion accessible molecules, based on 30 thousand...

Read on
Software
SeeSAR 11 - Hephaestus released!
May 5, 2021 12:38

Drug artisans prepare for the latest release of SeeSAR! SeeSAR 11 (codename: Hephaestus) comes with a myriad of innovations and tools, including covalent docking, 3D model export, in-depth binding site exploration, and many more. Get SeeSAR 11 here.

Read on
Webinars
Influencing Gαi/s Protein Activity by Peptidic Guanine Nucleotide Exchange Modulators
Fri, 21 May 2021, 16:00 CEST (Berlin)

For diseases such as cancer, the Gα subunits of heterotrimeric G proteins are attractive drug targets as alternatives to G protein-coupled receptors (GPCRs). Britta and Ajay contributed to the development of new modulators for the Gαi/s subfamilies providing insights into G protein-mediated signal transduction. In this work, two peptides were...

Read on

blue background Stay tuned Don’t miss
the latest news
Scroll Up